Man­u­fac­tur­ing roundup: Gen­Sight ter­mi­nates batch of gene ther­a­py; Evonik opens lipid pro­duc­tion site in Ger­many

Gen­Sight Bi­o­log­ics’ gene ther­a­py treat­ment for Leber hered­i­tary op­tic neu­ropa­thy, called Lumevoq, had an op­er­a­tional is­sue oc­cur dur­ing the man­u­fac­tur­ing process for one of its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER